Vesper Bio ApS
32879861ActiveA clinical-stage biotech company developing oral therapies for neurodegeneration.
Oversigt
- 7
- Medarbejdere
- Ukendt
- Omsætning
- 2010
- Grundlagt
Nøglebeslutningstagere
Anders Nykjær
Founder
Jacob Falck Hansen
Chief Executive Officer
John King-Underwood
Medicinal Chemistry
Graham Wynne
Medicinal Chemistry
+1 flere kontakter i Funnelfeedr
Beskrivelse
Vesper Bio is a clinical-stage biotechnology company dedicated to pioneering research in Sortilin biology. The organization focuses on developing innovative oral therapies for patients suffering from devastating and fatal disorders, specifically targeting Frontotemporal Degeneration. Founded on deep...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- APS
- Momsnummer
- DK32879861
Beslutningstagere
5 kontakter i FunnelfeedrAnders Nykjær
Founder
Jacob Falck Hansen
Chief Executive Officer
Andre kontakter
John King-Underwood
Medicinal Chemistry
Graham Wynne
Medicinal Chemistry
Andy Mulvaney
Business Development
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrNeumirna Therapeutics ApS
9 medarbejdereDeveloping miRNA-based therapies to treat complex neurological disease root causes.
CONTERA PHARMA A/S
19 medarbejdereDanish biotech company developing innovative RNA therapeutics for neurological disorders.
Vertanical Denmark ApS
23 medarbejdereInnovative biopharmaceutical company developing advanced cannabinoid-based chronic pain therapies.
Pephexia Therapeutics ApS
5 medarbejdereDeveloping innovative peptide-based therapies for treating cachexia and sarcopenia.
PAREXEL DENMARK A/S
20 medarbejdereLeading global clinical research organization accelerating life-changing medical treatments worldwide.
Udforsk mere
Spørgsmål om Vesper Bio ApS
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo